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Abstract 
Monozygotic (MZ) twins were long thought to be genetically identical, however recent studies 
have demonstrated genetic differences between them. To test the hypothesis that early post-
twinning mutational events leads to phenotypic discordance, we investigated a cohort of eleven 
twin pairs discordant for a variety of clinical phenotypes and two concordant twin pairs. 
Whole-exome sequencing (WES) data was analysed using a union of VarScan2 and MuTect2 
variant calling algorithms. Copy-number variation (CNV) analysis from Illumina HumanCore 
array data was also carried out using PennCNV and cnvPartition, and corroborated by 
computational validation with ExomeDepth. 
Five discordant variants were validated with Sanger sequencing, four of which were in the 
unaffected twin of an ALS-discordant pair (TMEM225B, KBTBD3, TUBGCP4, TFIP11), and 
one in the affected twin with lactase non-persistence (PLCB1). Parent-offspring trio analysis 
was implemented for two twin pairs to assess potential association of germline de novo 
mutations with susceptibility to disease. We identified a novel de novo mutation in RASD2 
shared by 8-year-old male twins concordant for a suspected diagnosis of autism spectrum 
disorder (ASD). RASD2 is enriched in the striatum and involved in the modulation of 
dopaminergic transmission. A de novo CNV duplication was also identified in these twins 
overlapping CD38, a gene implicated in social amnesia and ASD. In twins discordant for 
Tourette’s syndrome, an inherited stop loss mutation was detected in AADAC, a known 
candidate gene for the disorder. Moreover, a rare hemizygous deletion in region 15q13.2 was 
detected in twins with schizophrenia, overlapping ARHGAP11B, a human-specific gene 
involved in basal progenitor amplification and neocortex expansion.  
We provide evidence for de novo point mutations and CNVs in disease-related genes associated 
with a variety of clinical phenotypes present in MZ twins. We also found potentially pathogenic 
mutations shared by discordant twins, suggesting additional genetic mechanisms, including 
mutations in modifier genes and epigenetic changes, might also play a role in the phenotypes. 
Introduction 
Over the past decade, investigations of de novo mutations have challenged the assumption that 
MZ twins are genetically identical. It has been shown that the underlying genetic differences 
between co-twins, SNVs, indels, gene conversion, CNVs and postzygotic mitotic 
recombination, may arise during embryonic development. These variations have been proposed 
as potential genetic mechanisms resulting in discordant MZ twins (1). 
Post-twinning mutations result in somatic mosaicism, a phenomenon defined as two or more 
genetically distinct populations of cells in an individual that were developed from a single 
fertilised egg (2). 
Comparing the genomes of discordant MZ twins signifies a promising opportunity for the 
search of novel candidate variants implicated in disease, which may ultimately narrow the 
conceptual gap of missing heritability. With the cost of current NGS sequencing methods 
dramatically lowering, genome-wide comparisons of MZ twins can be made more affordable 
and readily available. This circumvents the need to focus merely on a set of candidate genes. 
Considering the estimated somatic mutation rate is extremely low and that these variants can 
be obfuscated by the relatively high error rate of NGS (3), a highly sensitive filtering method 
with high specificity, sequence resolution and coverage should be implemented. 
We performed WES and CNV analysis of DNA from eleven twin pairs discordant for a range 
of complex disorders, including two concordant twin pairs. With the aim to identify potential 
genetic factors that influence disease manifestation, it was hypothesised that de novo genetic 
mechanisms could increase the risk of disease onset. To investigate this hypothesis, the burden 
of rare SNVs, indels and CNVs overlapping disease-linked genes were analysed. For a twin 
pair discordant for Tourette’s syndrome and another pair where both exhibit signs of ASD we 
were able to perform parent-offspring trio analysis using DNA obtained from the parents. 
Materials and Methods 
Subjects 
Written informed consent was obtained from all participants prior to study entry. Further details 
of subjects can be found on Table 1. 
Whole-exome sequencing 
WES libraries were prepared with Agilent SureSelect V6 and sequenced on an Illumina 
HiSeq3000 using a 75-bp paired-end reads protocol. 
Sequencing data analysis 
Sequence alignment to the human reference genome (UCSC hg19), and variant calling and 
annotation was performed with our in-house pipeline. Briefly, this involves alignment with 
NovoAlign, removal of PCR-duplicates with Picard Tools followed by (sample-paired) local 
realignment around indels and germline variant calling with HaplotypeCaller according to the 
Genome Analysis Toolkit (GATK) best practices. 
Mosaic variants were identified with GATK MuTect2 (version 2.0) and VarScan2 (version 
2.4.3), using each pair as reference to one-another. The raw list of SNVs and indels were then 
filtered using ANNOVAR. Variants in splicing regions, 5’UTR, 3’UTR and protein-coding 
regions, such as missense, frameshift, stop loss and stop gain mutations, were considered. 
Priority was given to rare variants (<1% in public databases, including 1000 Genomes project, 
NHLBI Exome Variant Server, Complete Genomics 69, and Exome Aggregation Consortium). 
Furthermore, we have an in-house set of approximately six thousand exomes encompassing 
controls, rare diseases for cross-checking any shortlisted candidate variants, and for sequencing 
artefact removal. 
In silico prediction of pathogenicity was assessed using SIFT (4), PolyPhen2 (5), and 
MutationTaster (6). Conservation of nucleotides involved by variants was scored using 
Genomic Evolutionary Rate Profiling (GERP) (7). 
Variant validation by Sanger sequencing 
The DNA of five twin pairs was amplified by polymerase chain reaction (PCR), using primers 
specific to the candidate genes that had the resulting discordant SNVs (Table 2). Sanger 
sequencing was performed on an ABI 3730XL Genetic Analyzer (PE Applied Biosystems, 
Forest City, CA, USA) to validate the variants. Forward and reverse primer sequences for the 
candidate loci are listed in Supplementary Table 3. 
Genome-wide SNP genotyping 
Genotyping was performed according to the manufacturer’s instructions using the Illumina 
HumanCore v12 BeadChip (Illumina Inc., San Diego, CA, USA). In the quality control, sample 
sex and twin zygosity were genotypically confirmed, and samples with genotyping call rates 
<95% were excluded. 
CNV detection 
Log R Ratios (LRR) and B-allele frequencies (BAF) were generated using Illumina Genome 
Studio software (v2011.1) and used to call CNVs with PennCNV (8). CNV calling was 
performed following the standard protocol and adjusting for GC content. CNVs were then 
excluded if they were covered by <3 probes. After CNV merging, the remaining CNVs were 
visually re-evaluated using the GenomeStudio genotyping module. cnvPartition was used as 
the secondary CNV detection algorithm using the default parameters. All CNV coordinates are 
according to UCSC build 37/hg19. 
Computational validation by ExomeDepth 
The read count information was extracted from the individual BAM files using the R package 
Rsamtools. All reads were paired-end. Only reads with a Phred scaled mapping quality ≥20, 
distance of <1000bp from each other and in the correct orientation, were included. The location 
was defined by the middle location between the extreme ends of both paired reads. Exons closer 
than 50bp were merged into a single location owing to the inability to properly separate reads 
mapping to either of them. Parameters for ExomeDepth were applied according to the 
instructions provided by the user guide. 
This data was used to confirm CNVs detected by the SNP genotyping method. CN calls that 
were shared by all three calling algorithms (PennCNV, cnvPartition, and ExomeDepth) were 
considered high-confidence CNVs. 
Results 
Identifying discordant variants 
WES data were analysed by VarScan2 and MuTect2 using the annotated variant and genotype 
attained by the Haplotype Caller-based analysis as reference to explore the possible occurrence 
of low-frequency variants compatible with a mosaicism state. 
As there is a possibility of the unaffected twin having a de novo mutation that is not present in 
the affected twin, a reverse pairwise analysis was also performed where the affected twin was 
classified as the ‘normal’ sample and unaffected twin as the ‘tumour’ sample (Supplementary 
Tables 4 and 5). 
The resulting discordant variants were further filtered by excluding those variants that were 
likely to be non-functional, e.g., synonymous variants and/or variants outside the exonic 
regions. There are exceptions to this rule, such as for the twin pair discordant for lactase non-
persistence (KEL and KIR), where causally-linked variants can be found in intronic regions, 
with an MAF greater than 0.01. 
After applying our stringent filtering criteria, twenty putative discordant variants were 
identified, details for which can be found in Supplementary Table 6. However, only five of 
these variants were validated with Sanger sequencing (Table 2). Four of these discordant loci 
were in the unaffected twin of an ALS-discordant pair (242 and 243), and a somatic mutation 
was detected in the twin affected with lactase non-persistence (KEL and KIR) (Figure 1). 
Identifying shared pathogenic variants 
To test the hypothesis that rare, dominant or recessive variants could contribute to the complex 
disorders investigated, potentially damaging shared exonic variants were examined. Several 
variants were identified in known disease-associated loci that could potentially explain disease 
onset according to a model taking into account the possibility of incomplete penetrance.  
After application of the filtering criteria, each co-twin typically had 200 potentially damaging, 
rare shared variants. These were screened against lists of disease-specific susceptibility genes, 
which were obtained from various databases, including PubMed, OMIM, NIH GTR, 
DisGeNET, ALSoD, ALSGene, PDGene, SZDB, and SZGene. This produced a total of 113 
variants in the twin cohort; however, by manually reviewing them in IGV we could remove 
mutations that are obvious artefacts of short-read sequencing and alignment. Mutations that 
were unambiguous were retained. In total, 23 shared variants were identified in known disease-
susceptibility genes. These variants with their functional categories are shown in Table 3. 
Considering that the shared variants between co-twins were absent in all other samples, it 
would be extremely unlikely to obtain false-positives in the same gene location in both twin 
siblings. These were therefore not validated with Sanger sequencing. 
Parent-offspring trio analysis 
A total of 217,290 variants were called in GATK’s joint analysis. Variants shared by the MZ 
twins, but absent in their parents, were considered to be de novo germline mutations. After 
applying this initial exclusion criteria, a total of 424 and 412 putative de novo SNVs and indels 
were detected in twin pairs discordant for ASD and Tourette’s syndrome, respectively. Variants 
were further filtered as per similar parameters set for postzygotic de novo mutation detection. 
Upon manual review in IGV most variants could be excluded on the basis that they were falsely 
miscalled in one of the parents. However, a nonsynonymous mutation in RASD2, a gene 
encoding for a GTP-binding protein Rhes on chromosome 22 
(NM_014310:exon2:c.G170A:p.R57H), was found in the twin pair with ASD (discordant for 
severity). The variant is not reported in the dbSNP, 1000 Genomes, cg69 nor in the in-house 
database of 6,000 exomes. In the ExAC database containing more than 60,000 human exome 
data, the variant was found with an allele frequency of 8.13E-06 in the total population (allele 
count of 1/121112). The variant is also highly conserved across multiple species and predicted 
to be deleterious in online available bioinformatics tools. 
Because the father of the twins discordant for Tourette’s syndrome also had the condition, it is 
likely that both twins had inherited variants associated with the disorder. We focused our 
attention on variants consistent with a dominant mode of inheritance – namely, variants that 
are homozygous or heterozygous in the affected father, absent in the mother, and heterozygous 
in the twins. 
A filtering for rare or novel variants that were predicted to be damaging by at least one of the 
pathogenicity prediction tools led to the identification of 41 variants shared between the twins. 
Only one of the variants found to be inherited from the father has previously been implicated 
in Tourette’s syndrome, per our comprehensive list of 138 genes mined from various databases 
and search of literature. This was a stop loss mutation in AADAC, a gene encoding for 
arylacetamide deacetylase on chromosome 3 (NM_001086:exon5:c.T1198C:p.X400Q). This 
variant was also found in the shared pathogenic variant analysis. Both variants in the two 
families were validated with Sanger sequencing (Figure 2). 
Mitochondrial DNA analysis 
We next tested the hypothesis that different levels of mtDNA heteroplasmy might account for 
the phenotypic discordance between the twins. After applying a minimum read count threshold 
of 10, a total of 399 shared and discordant variants were identified between the twins. These 
variants included 34 heteroplasmic variants and 365 homoplasmic variants. A total of 36 
variants unique to either the affected or unaffected twin were verified using IGV. Among these, 
23 were distributed on 12 genes throughout the mitochondrial genome, and 8 were localised at 
the hypervariable segments HV1 (16024–16383) and HV2 (57–372). Most of the discordant 
variants came from twin pairs 421 and 422. These samples were excluded from further analysis 
due to the likelihood of artefacts created from high passage transformed immortalised cell lines. 
Variants in hypervariable segments were also removed. A novel nonsynonymous mutation in 
MT-ND5 (c.1260A:p.S420R) was detected in twin SUS, which was not present in the co-twin 
affected with ALS. Although this discordant variant had a high depth of coverage (with the 
number of reads ranging from 130 to 220), it could not be excluded or confirmed with Sanger 
sequencing due to a low allele fraction of 9%. 
Copy number variant analysis 
CNVs were called if they are covered by ≥3 probes to detect small CNVs that would potentially 
be filtered out of the data. As this is expected to result in a higher frequency of false positive 
calls, CNVs were also called using cnvPartition, and CN segments were only included in 
further analysis if the CN calls agreed between both algorithms. The results obtained from SNP 
array analysis are summarised in Supplementary Table 7. These putative CNVs were compared 
against WES CNV calls using ExomeDepth. CN calls that were shared by all three calling 
algorithms were considered for downstream analysis (Table 4). 
For the shared CNVs, we focused on subsets of genes that are associated with known 
phenotypes in disease databases such as OMIM and DisGeNET, or genes that are intolerant to 
LoF mutations based on the Residual Variation Intolerance Score (RVIS) or the probability of 
being loss-of-function intolerant (pLI) score (9). An RVIS <0.0 means that a given gene has 
less common functional variation than expected, and is referred to as ‘intolerant’; whereas an 
RVIS >0.0 indicates that a gene has more common functional variation. Genes with high pLI 
scores (pLI ≥ 0.9) are extremely LoF intolerant, whereas genes with low pLI scores (pLI ≤ 0.1) 
are LoF tolerant (Table 4). 
No CNV differences between co-twins or tissue types within a single individual were found. 
Four pre-twinning de novo CNVs were identified by the CN calling algorithms used but were 
not experimentally validated. Three were found to not overlap any genes or regulatory regions, 
and one was a CNV duplication found in the twins exhibiting signs of ASD (OH and RP), 
overlapping >85% proximal of CD38. This shared de novo CNV was also called by 
ExomeDepth, and will be validated with droplet digital PCR as part of a future study. 
Discussion 
De novo mutation detection in parent-offspring trio analysis 
Behavioural abnormalities: ADDitude 
A nonsynonymous mutation (c.G170A:p.R57H) within the RASD family member 2 (RASD2) 
was found in both twins with a suspected diagnosis of ASD and behavioural problems (OH and 
RP), but absent in their parents. RASD2 belongs to the Ras superfamily of small GTPases and 
is enriched in the striatum and involved in the modulation of dopaminergic neurotransmission 
(10). RASD2 is located on chromosome 22q12.3, a region that harbours numerous susceptibility 
loci for psychosis (11), and has been suggested to be a vulnerability gene for 
neuropsychologically defined subgroups of schizophrenic patients (12). Currently, the co-twin 
has not been officially diagnosed but anecdotally has been showing clinical features of ASD.  
In a knockout mice model with targeted deletion of Rasd2, Vitucci et al. (10) found that the 
absence of Rasd2 significantly increases the behavioural sensitivity to motor stimulation with 
administration of psychotomimetic drugs, such as amphetamine and phencyclidine. Based on 
these findings, and the postulate that RASD2 influences prefronto-striatal phenotypes in 
humans, the authors hypothesise that a genetic mutation resulting in a reduction of this G-
protein might play a role in cerebral circuitry dysfunction, resulting in exaggerated 
psychotomimetic drug responses and the development of specific phenotypes linked to 
schizophrenia-like symptoms (10). 
Tourette's syndrome: What makes one tic? 
No pathogenic germline de novo mutations were identified in the twin pair. However, a shared 
stop loss mutation in AADAC, a gene encoding for arylacetamide deacetylase on chromosome 
3 (NM_001086:exon5:c.T1198C:p.X400Q), was inherited from the father.  
In a meta-analysis of 1181 patients and 118,730 control subjects, Bertelsen et al. (13) 
determined a significant association between AADAC and Tourette’s syndrome. Further, 
functional studies demonstrated that AADAC is expressed in several brain regions previously 
implicated in the pathophysiology of Tourette’s syndrome, including the Purkinje cell layer of 
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the human cerebellum (13). CNVs overlapping AADAC are the first to be successfully 
associated with Tourette’s syndrome. More recently, Yuan et al. (14) found that variants in 
AADAC may be a candidate factor for Tourette’s syndrome development in a Han Chinese 
cohort. 
Remarkably, transcriptome profiling data from The BrainSpan Atlas of the Developing Human 
Brain (http://www.brainspan.org) illustrates that AADAC expression peaks in the striatum 
between birth and adolescence. This is consistent with the typical clinical time course of tic 
onset, and indeed the age of onset of Tourette’s syndrome in the father and the affected twin 
investigated herein. Considering the above evidence, the stop loss mutation detected in the 
father and twins warrants functional studies to investigate the role of AADAC in the 
pathogenesis of this disorder. 
Discordant single nucleotide and indel variants 
WES analysis yielded twenty high-confidence discordant variants within the thirteen twin pairs 
investigated (Supplementary Table 6). We successfully validated five of these in two twin 
pairs. The success rate of 20% may be due to the limited sensitivity of Sanger sequencing, 
and thus the variants that were not confirmed may not all be false positives. Validation with 
a method capable of detecting low-level mosaicism is warranted, such as ddPCR, which can 
detect mutations with allele fractions of 0.001% (15). 
In the ALS-discordant pair, two discordant nonsynonymous variants were identified in 
KBTBD3 and TUBGCP4, and two frameshift deletions in TMEM225B and TFIP11 (Table 2). 
Although these mutations were predicted to disrupt protein function, this cannot be reconciled 
with the fact that they were detected in the unaffected twin. Nevertheless, it is possible that 
these somatic mutations contributed to the phenotypic discordance by having disease-
modifying effects in the unaffected twin. Commented [GU2]: protective? 
A somatic frameshift deletion in PLCB1 was also detected in a buccal sample derived from the 
affected twin with lactase non-persistence. PLCB1 is expressed predominantly in neurons of 
the central nervous system and is not abundantly expressed in other tissues or cell types (16). 
In dairy cows, this protein has been shown to hydrolyse most of the lipid phosphorus in the 
low- and high-density lipoprotein fractions of milk (17). However, the role of this gene in 
digestive system disorders remains unclear, thus warranting further investigations to verify the 
significance of this mutation, if any, in lactase non-persistence. 
Shared single nucleotide and indel variants 
In addition to identifying discordant variants, we sought to examine shared variants with 
predicted pathogenicity. This included rare homozygous and heterozygous variants, and those 
in known disease-susceptibility genes. Phenotypic discordance between twin pairs could be 
explained in several ways. For instance, if the variants exhibited incomplete penetrance, the 
unaffected twin could develop the disorder later. Of note, we document a shared pathogenic 
hexanucleotide repeat expansion in ALS-discordant twins 421 and 422 (Supplementary 
Results). Oligogenic mechanisms may also be a factor. 
Shared variants in exonic, splice site, promotor, 5’UTR and 3’UTR regions were cross-
compared against a list of disease-linked genes formulated via a comprehensive search of 
literature and gene databases. The number of concordant variants could be further reduced by 
removing those found in multiple other samples, repetitive sequences or systematic 
mismapping of paralogous sequences. 
As there will likely be a larger number of shared variants in novel genes (previously not related 
to the primary diagnosis of the affected twin), the search was restricted to only nonsynonymous 
variants in exonic regions (data not shown). The concordant variants found in WES should 
ideally be validated with an independent method. Nevertheless, it would be very unlikely for 
both twins to receive false-positive readings at the same gene location. The lists of concordant 
variants identified within each twin pair will thus be of use to future genetic studies related to 
the disorders investigated. 
Copy number shared variants 
A shared de novo CNV duplication was detected in twins with a suspected diagnosis of ASD 
(discordant for severity), overlapping CD38, a gene implicated in ADHD (18), social memory, 
amnesia and ASD (19). Although our results don’t demonstrate CNV contribution to 
phenotypic MZ discordance, the pre-twinning structural events detected in this twin cohort 
could represent a susceptible genetic background (Table 4). 
Schizophrenia: Mind the GAP. 
A deletion in ARHGAP11B (CN = 1) and a duplication in ARHGAP5 (CN = 3) were identified 
in schizophrenia-discordant twin pairs RT1a/RT1b and IP16/IP17, respectively 
(Supplementary Figures 7 and 8). ARHGAP gene products belong to the Rho family of GTP-
binding proteins, which are involved in membrane/cytoskeletal reorganisation events. There 
are approximately 80 distinct RhoGAP domain-containing proteins that are encoded in human 
DNA. 
The ARHGAP5 gene product (a GTPase-activating protein for Rho family members) is linked 
to Ras, and thus to EGF receptor-mediated proliferation, migration and differentiation of 
forebrain progenitors (20). Therefore, an ARHGAP5 duplication in an MZ twin pair discordant 
for schizophrenia might point to an aetiological basis, because schizophrenia has been linked 
to altered prenatal neurogenesis of cortical neurons (21). In addition, ARHGAP5 and 
ARHGAP11B are contained within regions 14q12 and 15q13.2, respectively, which have 
previously been associated with schizophrenia (22,23). 
Of special mention is the gene ARHGAP11B, which resides on chromosome 15q13.2, one of 
the most complex and unstable loci in the human genome. Several neurodevelopmental 
disorders have been linked to structural variants in this and nearby regions (24,25). 
ARHGAP11B arose from partial duplication of ARHGAP11A in the human lineage, 
approximately one million years after divergence from chimpanzees, but before divergence 
from Neanderthals (26). This led to the formation of large and complex human-specific 
segmental duplications, mediating recurrent rearrangements contributing to 15q13.3 
microdeletion syndrome associated with intellectual disability, epilepsy and schizophrenia 
(27). Remarkably, all events were related to the chromosome 15 core duplicon containing 
GOLGA, suggesting that these sequences have a fundamental role in the cycles of chromosomal 
rearrangement and segmental duplication expansions (24). GOLGA sequences might possess 
favoured sites for microhomology-mediated break-induced replication, mechanisms which 
may induce segmental duplication formations (27). 
ARHGAP11B is, to date, the only human-specific gene shown to promote basal progenitor 
generation and proliferation, including cortical plate augmentation and gyrification induction, 
and has been proposed to play an important role in the evolutionary expansion of the human 
neocortex (26). 
The duplicated 8 exons of ARHGAP11A is almost identical to the paralogous sequence of 
ARHGAP11B, and thus is not completely queried in high throughput genetic studies. Indeed, 
variations in this region have flown below the radar of available genome-wide technologies, 
which likely has downplayed its hypothesised associations with neurodevelopmental disorders. 
Because of the genomic complexity of the region, the extent of human structural diversity and 
breakpoints of most rearrangement events are poorly understood at the molecular genetic level. 
Moreover, the wide expression of ARHGAP11B, its multiple functions and modes of regulation 
– not to mention its absence in non-human animals – present challenges for its study in disease. 
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Several RhoGAPs have been linked to schizophrenia. For example, a study reported an 
association between variation in ARHGAP32, which encodes a neuron-associated GTPase-
activating protein, and schizophrenia and schizotypal personality traits (28). ARHGAP33 
regulates synapse development and autistic-like behaviour (29). A missense polymorphism in 
ARHGAP3 has been associated with schizophrenia in men (30). Further, in a genome-wide 
association study from the Han Chinese population, Wong et al. (31) identified a schizophrenia 
susceptibility locus on Xq28, which harbours the gene ARHGAP4. 
This study shows that segmental duplications play an important role in normal variation as well 
as in genomic disease, defining hotspots of rearrangement that are susceptible to variation 
among the normal population. Considering the above findings, we propose that both ARHGAP5 
and ARHGAP11B are potentially associated with neuropsychiatric disorders, and this 
preliminary study provides the necessary baseline to begin future studies on disease 
populations. 
Conclusion 
This study supports the polygenic nature of the complex disorders investigated and the 
threshold model for their manifestation. The discordant MZ twin strategy employed in this 
study to identify candidate genes involved in the pathogenesis of complex traits is reasonable 
and practical. Notwithstanding, the actual search for discordant variants is not an easy task. For 
some of the twin pairs, no discordant variants were identified, and the shared variants present 
in disease-susceptibility genes do not explain the twins’ discordant phenotypes. This suggests 
that genetic alterations in these twins might lie outside the accessible exonic regions. 
Future research directions include systematic whole-genome, methylome, transcriptome and 
proteome analyses on discordant MZ twins, to identify novel disease-causing candidate genes 
and elucidate the role of differential gene expression in complex disorders. 
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Titles and Legends to Figures 
Figure 1. IGV screenshots and electropherograms confirming somatic mutations in twins 
discordant for ALS (242 and 243) and lactase non-persistence (KEL and KIR).  
Figure 2. IGV screenshots and electropherograms confirming a germline de novo and inherited 
mutation. a. A germline de novo mutation in RASD2 in twins with behavioural issues and 
suspected autism (OH and RP), which is absent in their parents (DS and DV). b. A stop loss 
mutation detected in AADAC in twins discordant for Tourette’s syndrome, inherited from the 
affected father. 
 
